pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-655 |
Genomic Coordinates | chr14: 101049550 - 101049646 |
Synonyms | MIRN655, hsa-mir-655, MIR655 |
Description | Homo sapiens miR-655 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-655-5p | ||||||||||||||||||||||||||||||
Sequence | 23| AGAGGUUAUCCGUGUUAUGUUC |44 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SMIM13 | ||||||||||||||||||||
Synonyms | C6orf228 | ||||||||||||||||||||
Description | small integral membrane protein 13 | ||||||||||||||||||||
Transcript | NM_001135575 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SMIM13 | |||||||||||||||||||||
3'UTR of SMIM13 (miRNA target sites are highlighted) |
>SMIM13|NM_001135575|3'UTR 1 TCCTGTACTTGTGAAGGATGAAAAGGCAGTTGCCAGCTTCTGTCTTTTACTGACTTCGCTTTGAAATTTACTAATGACTG 81 AAGAACATTTGTATTGGATTTTAAGTCGAATTTTAAAAAAGATTTACATGTAAGCCATATAAAAATAAAGGGAACTGAAA 161 CCAAATTGGACTATTATAAATTTCATCTTAAAGATAATCTTTTGTTTCACCAGCTTTCTACTTATACACTTATTCCTTGG 241 CTTTTGGGCTTATTTTCTTGCACTGGTGCAGATCTGGTAAACATTAAAGGCTTGAAAAACCATATTTTGTTAGCCCTAAA 321 ATGTACATTTTTCTTCCCATTTTAACTTATCTGAAATTGGGATGCATCTCATTACTGTCAACCAGGTGATAGTCATGTAA 401 CGCTCCTACCGTGTGCATGTGTGAATTTACAGCTTGTCATCGTGTCATCCCTTTAACCAACATGTGTTTTGTTGGTATCA 481 AATGTGTCAGGTTTAATTGACATTTTAAAATGTCTTCAAAAAGATCACACTATGATTCAGCATTGAAACGAAAAGTTATT 561 GTGTATGCAGAAAAGCATGGAAACAGAGCAGCAGGGCGTACATTTGATATTAGTGAAGCAAATATTCGTCGCTGGAGAAA 641 TGATCGCAATTCCATATTTTCCTGCAAAGCAACAACAAAATGTTTTACGGGACCTAAGAAAGGTAGGTACCCACAAGTAG 721 ATGAAGCTGTACTACGTTTCGTCAGTGAGACACGTGCAAAAGGATTGCCTATCACACGCCAAGCAATGCAATTGAAGGCA 801 GGAGAAGTTGCCAAAACCCTAGGAATTGATGAAACAAAATTCAAAGCCACAAGAGGCTGGTGTGACCGATTCATGCGTCG 881 AGCAGGACTATCATTAAGGCATCAAACATCGTTTTGTCCCAAGCTCCCCACTGCCATTAAACAGAAGACAGTGTTGGAGC 961 ACTCTTTCAAGAAGTGCTGCATAACCAGTACTCTTGACAACACCGGGAGAGACGTTCTGTGGAAAAATGCAGACATCAAT 1041 GACTGTGGTTTGAAAAGTGATTCAGAAGAGTTGGATTCAGAATATGAAGTTATAATTATAACTTAACCAATTTATTTCAC 1121 ACATTTTCTTTACATATGCACAAGATTGATGTGATAAAAATCTGTTTAACTCAAAGCGCTGTTTCAATAAATATAAACAT 1201 TTTCTGTGATATGAAAGCATTGTGTCATAGTTTAATGGGCAGTGTTTTTTCTTAGTGATACATATGGTGCATCTTAACAA 1281 TTGGTAGTGTCTTAGGTTAAATTAAAAATGGTAGCTTGTAAATTTATTTTTCTTTTTAAGATAGCAGTTATTTATTGGGG 1361 AATTTGATTCTGACTCTTACAATGTTAAACTTGTAATCCTGTGTGAAACACATGTTTTTGGGGGGGAGGGGGTAACCAAG 1441 ATTTCAGGGTAGTAACTTAGGAATCTAAGAACTATCTTCTACTTTAGGAAGAGTGGGATTAGTTACTCCCTTTGTATAGG 1521 AGGACTTTATGCTCAAGGAATGTGTTGTGGAGAAAAACACTTCTTCACAAACAATTCAGTGACAAGACCTCAAAGGTAAT 1601 GCGTATTGAGGAAAACAGTAGTGGGTGAAAATTCCCGCTTAGCTGTAAAATGACTCTCTTGCCAGGTTTCCGTGTTTGTC 1681 TCAACTGAACTCTGGGCTGAGTGTTTACCAGGGAGAAGAGATGTGAATTAAACAACCTTCCTGTTTAGTGTTACCTGCTT 1761 TGTACAAGAATGAAGTGCAAAGCCAACTTACTTTATTAATCCAAGTTCTTTTTATGTTTTTCTTAACCTTTATTAAGGAC 1841 TAGTCATCACAAAATATCTATTTAACCTCTATTTTATGATGGTGTGTTATTATGTTTGATACCTCATACTTCTTGCTTAG 1921 AGTTTTGTTTAACAGTTCACTGGCTCTGTCCCAATGTTTGTGATGAACACCTTTTTGCTATATTGTAGCTCTTGGAGATA 2001 CTAAAAGAGAATTCACAGAACATAACTTTAGTTTTATGTGTTTGCTAGGGGAAGATTTCCTAGCAGCTGAGAGCAAGGCA 2081 CAGTCTCTGTCTTCATTTCTTTATTAGATACAATTTTCTATTTTTATGTGACTCTAGGGCATAACAAAACAGTGACAGTT 2161 TCAAGCGTTAATTTTAATGCTTCCTACTAGCTAAATATCATCTTAAAATGATTATCAGAAAAAAAAATAATGCCCCCAAA 2241 AACTTTTGGGGGCATTATTTGGTACTGGGAGGATATTTAAATTAGATTTTTCATAGTCTATTGTTTTGAACTATGGATTC 2321 TGTTTTATGGTGGATACCTAAGGTTTATATAATAGTTGCTGGAAAACTTAAAGTAGCTGGTGAGCTTCCTGTTATGTCAC 2401 TATTAAAGAATGATGGCTGATGTAACTCTGCCCCTGAAATCTACAAGGGTCATGCCCAAATTAATACAGGTTAACCTTTG 2481 TAGAGGTATATATGTTGGCATTATTTATTGACATTTATGCTTCAAGCATGTCTTATTTTATGTAATTTTAAGAAATACTC 2561 TATTTAACTTGTGAAATATACCTAAAAGCATACTAGTTAGCTCTTAGACTCTCACTTAGGGAGGGTAAAGAAACATCACT 2641 GATGCCAATATGAAGATCTATAAACAAATCCTTTGTTTAGAACTTTTTTCTCTTCGTGCACCTCACAACACACTTACCAT 2721 GGTACATATTTCTTAATGCCACTAAGAAAGGCAAGATAGTGAACGCAGAATTATTTATGTGGTATAGTGTTTGTTTTCCT 2801 GTTTTAGTGCTTTTGTAGCTAAAACTTACTGGAACTGCATCACAACTACATTTGCAGTCTCAGTGGGAGGTGGACTAGCC 2881 TGTGGTTAATTTTAGAGCTTAAAAGTTTATAAGCATTAAAAACACATACATGTATTAGAATCTTGTCTAACCCCTCACAA 2961 AGGATGATGGTGATCAGCATGCCATCTTTTGAAGATTAATTCTAAAATTGAGGACTCTGGTAGGTTGTTTTATTTCCTTC 3041 CCAACCAGCCATTCATTTCCAATTGTTCTGCCTTTGAAACTTTTTGTGAAAATTGCCTGTACCAATTGCATTGGTTGCGT 3121 TGCTCTGATTTAAATGCCAAAAACACTAAATATTTGTGTAGTGCTGTTAAATGAGGTTTTTGATATTTCCATCAAAATGA 3201 ATATAAAATTCACTTGATGGATTTTGTAGTGATGTTTTCACAGTTGAAACAAACATATTGCTGTGCGGTGGACAGCCACT 3281 TCACAGACATGCAGACCCATTTCTTTAGAGATATTAGGTTTAAAACCCATTTTAATTTTATTTTGCTGAAGGTTTGGAAT 3361 ATATAAAGTAATGGATTCACAAAATATGATATCTTAAAACATGTTGAAAGATTTGAAAGTGGTGCATTTTTACTTTTAAG 3441 AGCAGCAATCTTTGAAATTAGTCAACAATGCAGTCTTTTTTAAAAGTCAGTTTTCTCAAGTAGTATGTTGTAACGTAAGA 3521 TGTAACTGATATAACTAGATTTTGACTGGTAAACTTAAAGTGCTTTTTATATTTGAGGTTGACTTTAAAAAGCCATTGAG 3601 CAGTCCTCAGAGGTTATGGACTCTCAAGCGACTAATGGAATAGTGTTCTGTTGTGAAGTCTAGAACTAAAGCACCTTGTA 3681 TTGTCTGCTTCTAAAGTGTCCTATAGTTTTTAACTTAAAGTGTAAAGAGTAACATTTTATCTTATGTCAATTAAAGTTAC 3761 ATTTTTCATTTGTTGGTGTACATGTGCTACCTGTTTTATGGGGAATGTTTAACACGATCCTCCAAGTTGGTTCTATGCAT 3841 AACCATTCACCAAATACTGCTGCTGTGATTCCTTGAAGGAAATATTCTGTGGTCTGCTATGATGCATTGCCATCTTGCTG 3921 CTTGACAATAGGTTTATAAATAATTAGAATTACGTGTTTTAATAGTACCTTTGTATATATAACAAGATGTAAAATTAAAG 4001 ATGAGGAATGTGTGTAAATGATCATTCACTGTTTTTGTTTTAAAACTGGTCAGTACTATGAAGCTTCTGTGGTTTGTATG 4081 ATGTTTTAACTTTCACTTTAAACTGCATAGAATAAATTAAATTGAAAACAACAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000416247.2 | 3UTR | UCAUCACAAAAUAUCUAUUUAACCUCUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
91 hsa-miR-655-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT080691 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT095086 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 4 | ||||||||
MIRT122450 | SMIM13 | small integral membrane protein 13 | 2 | 2 | ||||||||
MIRT214635 | SMAD5 | SMAD family member 5 | 2 | 4 | ||||||||
MIRT268267 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT312418 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 2 | ||||||||
MIRT329008 | DSTN | destrin, actin depolymerizing factor | 2 | 2 | ||||||||
MIRT329824 | PDCD4 | programmed cell death 4 | 2 | 4 | ||||||||
MIRT389635 | LRRC58 | leucine rich repeat containing 58 | 2 | 6 | ||||||||
MIRT443969 | FAM198B | family with sequence similarity 198 member B | 2 | 2 | ||||||||
MIRT444080 | C12orf73 | chromosome 12 open reading frame 73 | 2 | 2 | ||||||||
MIRT444886 | TMEM196 | transmembrane protein 196 | 2 | 2 | ||||||||
MIRT445506 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | 2 | 4 | ||||||||
MIRT446292 | ACSL3 | acyl-CoA synthetase long chain family member 3 | 2 | 2 | ||||||||
MIRT446462 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT446472 | THUMPD3 | THUMP domain containing 3 | 2 | 2 | ||||||||
MIRT447413 | MED21 | mediator complex subunit 21 | 2 | 2 | ||||||||
MIRT447491 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT448965 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | 2 | 2 | ||||||||
MIRT449602 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT449607 | PRPF4 | pre-mRNA processing factor 4 | 2 | 2 | ||||||||
MIRT449737 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 2 | 2 | ||||||||
MIRT451668 | KRT8 | keratin 8 | 2 | 4 | ||||||||
MIRT452424 | QDPR | quinoid dihydropteridine reductase | 2 | 2 | ||||||||
MIRT455187 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT456059 | SLC25A28 | solute carrier family 25 member 28 | 2 | 2 | ||||||||
MIRT456488 | SERAC1 | serine active site containing 1 | 2 | 2 | ||||||||
MIRT456631 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT459621 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT461162 | SLC11A2 | solute carrier family 11 member 2 | 2 | 4 | ||||||||
MIRT461990 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT463149 | ZNF385A | zinc finger protein 385A | 2 | 4 | ||||||||
MIRT463465 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463801 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT464010 | WDR26 | WD repeat domain 26 | 2 | 2 | ||||||||
MIRT465302 | TRIB1 | tribbles pseudokinase 1 | 2 | 2 | ||||||||
MIRT468837 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT469132 | RNF126 | ring finger protein 126 | 2 | 2 | ||||||||
MIRT469244 | RHOB | ras homolog family member B | 2 | 2 | ||||||||
MIRT472414 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT472432 | NCBP2 | nuclear cap binding protein subunit 2 | 2 | 2 | ||||||||
MIRT472808 | MTMR12 | myotubularin related protein 12 | 2 | 2 | ||||||||
MIRT477893 | DVL3 | dishevelled segment polarity protein 3 | 2 | 4 | ||||||||
MIRT477963 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | 2 | 2 | ||||||||
MIRT479258 | CHSY1 | chondroitin sulfate synthase 1 | 2 | 2 | ||||||||
MIRT479718 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT480231 | C9orf41 | carnosine N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT482600 | ABHD14B | abhydrolase domain containing 14B | 2 | 2 | ||||||||
MIRT483096 | TFPI | tissue factor pathway inhibitor | 2 | 2 | ||||||||
MIRT484644 | TBC1D5 | TBC1 domain family member 5 | 2 | 4 | ||||||||
MIRT488899 | CLDND1 | claudin domain containing 1 | 2 | 2 | ||||||||
MIRT491954 | VPS52 | VPS52, GARP complex subunit | 2 | 2 | ||||||||
MIRT496937 | LBR | lamin B receptor | 2 | 2 | ||||||||
MIRT498546 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT501778 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT516286 | DBT | dihydrolipoamide branched chain transacylase E2 | 2 | 2 | ||||||||
MIRT516351 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT516751 | ZNF100 | zinc finger protein 100 | 2 | 2 | ||||||||
MIRT517939 | ZNF431 | zinc finger protein 431 | 2 | 4 | ||||||||
MIRT518295 | ZNF514 | zinc finger protein 514 | 2 | 4 | ||||||||
MIRT518515 | CASP10 | caspase 10 | 2 | 2 | ||||||||
MIRT519017 | NOA1 | nitric oxide associated 1 | 2 | 2 | ||||||||
MIRT519171 | SCO1 | SCO1, cytochrome c oxidase assembly protein | 2 | 2 | ||||||||
MIRT519470 | SPTLC2 | serine palmitoyltransferase long chain base subunit 2 | 2 | 2 | ||||||||
MIRT521029 | SLC30A5 | solute carrier family 30 member 5 | 2 | 2 | ||||||||
MIRT521251 | SAMD8 | sterile alpha motif domain containing 8 | 2 | 2 | ||||||||
MIRT521682 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | 2 | 2 | ||||||||
MIRT529386 | SKP1 | S-phase kinase associated protein 1 | 2 | 2 | ||||||||
MIRT545507 | NAP1L1 | nucleosome assembly protein 1 like 1 | 2 | 2 | ||||||||
MIRT549655 | RSL1D1 | ribosomal L1 domain containing 1 | 2 | 2 | ||||||||
MIRT551041 | CTSB | cathepsin B | 2 | 4 | ||||||||
MIRT551441 | ZNF490 | zinc finger protein 490 | 2 | 4 | ||||||||
MIRT554778 | RHEBP1 | RHEB pseudogene 1 | 2 | 4 | ||||||||
MIRT565793 | SEC14L5 | SEC14 like lipid binding 5 | 2 | 2 | ||||||||
MIRT566727 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT574668 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | 2 | 2 | ||||||||
MIRT610128 | DENND5B | DENN domain containing 5B | 2 | 2 | ||||||||
MIRT624919 | FBXW2 | F-box and WD repeat domain containing 2 | 2 | 2 | ||||||||
MIRT641830 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT662165 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT667150 | NRXN3 | neurexin 3 | 2 | 2 | ||||||||
MIRT689085 | ADNP2 | ADNP homeobox 2 | 2 | 2 | ||||||||
MIRT696322 | DCAF15 | DDB1 and CUL4 associated factor 15 | 2 | 2 | ||||||||
MIRT699062 | SNX4 | sorting nexin 4 | 2 | 2 | ||||||||
MIRT703229 | GOLGA1 | golgin A1 | 2 | 2 | ||||||||
MIRT705743 | AMD1 | adenosylmethionine decarboxylase 1 | 2 | 2 | ||||||||
MIRT706087 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 | ||||||||
MIRT709288 | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 2 | 2 | ||||||||
MIRT711457 | RNF145 | ring finger protein 145 | 2 | 2 | ||||||||
MIRT714708 | PPP3CC | protein phosphatase 3 catalytic subunit gamma | 2 | 2 | ||||||||
MIRT719871 | CYP4F11 | cytochrome P450 family 4 subfamily F member 11 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|